COMPUTED DESCRIPTORS
| Molecular Weight | 1864.1 g/mol |
|---|---|
| XLogP3 | -3.5 |
| Hydrogen Bond Donor Count | 24 |
| Hydrogen Bond Acceptor Count | 29 |
| Rotatable Bond Count | 23 |
| Exact Mass | 1862.83447922 g/mol |
| Monoisotopic Mass | 1862.83447922 g/mol |
| Topological Polar Surface Area | 757 Ų |
| Heavy Atom Count | 131 |
| Formal Charge | 0 |
| Complexity | 3970 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 16 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Balixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).